Figure 2From: Pilot study of 89Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancerComparison of89Zr-bevacizumab SUV peak and TBR in different tissues. The values were compared at day 4 (open bars) and day 7 (black bars). AD, aorta descendens; FT, fatty tissue; HL, healthy lung; LNM, lymph node metastasis; M, muscle; NLNM, non-lymph node metastasis; PT, primary tumor; TBR, tumor-to-blood ratio.Back to article page